nasal

AstraZeneca’s COVID vaccine suffers a setback in nasal spray trial

October 10, 2022

(Reuters) – Attempts by Oxford University researchers and AstraZeneca Plc

Lottery confusion turns into $50K win for Carroll County player
Catonsville player cashes in $50K during jackpot night next door
Maryland man turns spare tips into $100K lottery win
New Jersey grand jury indicts Woodbridge police sergeant in fatal 2025 shooting
Florida funeral home hit with default judgment over alleged mishandling of stillborn infant